Icon Investors File Lawsuit Against Major Shareholder Linked to Chinese Communist Party
On June 1, Icon Aircraft founder Kirk Hawkins and other minority shareholders of the company filed a lawsuit against the company’s majority shareholder Pudong Science and Technology Investment Inc. (PDSTI) in Delaware Chancery Court (Docket No. 2021-0475). The minority group also includes a former Icon board member and former Boeing CEO Phil Condit.
According to Aviation International News, the minority shareholders are accusing PDSTI of seizing control of the management of the company, breaching their fiduciary duty to shareholders, removing minority American board members, and blocking the company’s takeover negotiations with Yamaha. The moves are “all in support of its goal to expropriate Icon’s intellectual property to China,” reported AV Web, a global aviation news portal, on June 8, 2021.
NIO Inc (NYSE:NIO) - Nio Names Chinese Businesswoman Yu Long As Independent Board Director
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
NIO Inc (NIO) Appoints Ms Yu Long as Independent Director
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Rising tides: Avant eyes retail launch of cell-based fish maw and fillet by 2025 - CEO interview Hong Kong’s cultivated meat biotechnology firm Avant is aiming to produce its first cell-based fish maw and fillet products for consumption by late 2022, and wants products to be commonplace in supermarkets by 2025.
It first launched the cell-based fish maw prototype in 2019, and the cell-based fish fillet in 2020, and now hopes to manufacture these in a soon-to-be set up pilot plant in Singapore by late 2022.
Once it receives approval from Singapore’s regulatory body, the Singapore Food Agency (SFA), Avant will initially produce for foodservice first, and target the larger retail sector sometime in 2025.
Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.